Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
Table 2
Prevalence of MS and MS components in PCOS patients ().
Variable
Controls ()
PCOS ()
value
Prevalence of MS, (%)
6 (2.99)
41 (20.50)
29.723
<0.001
Occurrence of each component of MS, (%)
WC ≥ 80 cm
50 (24.88)
87 (43.50)
15.460
<0.001
TG > 1.7 mmol/L
10 (4.98)
39 (19.50)
19.718
<0.001
HDL-C < 1.29 mmol/L
57 (28.36)
102 (51.0)
21.477
<0.001
SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg
7 (3.48)
27 (13.50)
12.964
<0.001
FG > 5.6 mmol/L
3 (1.49)
11 (5.50)
4.778
0.029
Number of MS criteria, (%)
47.876
<0.001
0
103 (51.24)
58 (29.0)
1
73 (36.32)
69 (34.50)
2
19 (9.45)
32 (16.0)
3
6 (2.99)
33 (16.5)
4
—
6 (3.0)
5
—
2 (1.0)
Data are expressed as the number (%) of patients. The bold values represent differences that were considered statistically significant at .